DOJ Puts Teeth in Sunshine Act Reporting Requirements

Recent settlements between the Department of Justice and a range of FDA-regulated drug and medical device manufacturers provide a snapshot of the DOJ’s enforcement focus. These settlements involve new DOJ theories of liability or new ways of evaluating long-standing industry practices and may be harbingers of future DOJ enforcement activity. In a six-part series of […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.